Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: Long Island City NY, Manhattan NY, Fairfax VA,
Sponsor: Accent Therapeutics

Sex: All

Age: 18+

Code: NCT06799065

Phase 1, Phase 2, Recruiting

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

for
Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B,
Location: Memphis TN, Fridley MN, Minneapolis MN, Coon Rapids MN,
Sponsor: Helio Genomics

Sex: All

Age: 18+

Code: NCT05181826

Recruiting

Multi-Cancer Early Detection (MCED) of Firefighters

for
Cancer
Location: Scottsdale AZ
Sponsor: Vincere Cancer Center

Sex: All

Age: 18+

Code: NCT05780957

Recruiting

A Crowd Sourcing Platform for Patients With Cancer

for
Cancer
Location: Seattle WA
Sponsor: All4Cure

Sex: All

Age: 18+

Code: NCT03530826

Recruiting

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

for
Advanced Solid Tumor, Metastatic Breast Cancer
Location: Lake Mary FL, Sarasota FL, Nashville TN, Houston TX
Sponsor: Edgewood Oncology Inc.

Sex: All

Age: 18+

Code: NCT04872166

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

for
Lung Cancer, Non-small Cell, Lung Cancer Metastatic,
Location: Weston FL, Canton OH, Cleveland OH, Detroit MI,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06228326

Phase 1, Phase 2, Recruiting

ALG.APV-527 First-in-human Study

for
Solid Tumor
Location: Port Saint Lucie FL
Sponsor: Aptevo Therapeutics

Sex: All

Age: 18+

Code: NCT05934539

Phase 1, Phase 2, Recruiting

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

for
Advanced Solid Tumor
Location: San Antonio TX
Sponsor: PharmaMar

Sex: All

Age: 18+

Code: NCT05841563

Phase 1, Recruiting

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

for
Metastatic Malignant Neoplasm in the Brain,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06328686

Early Phase 1, Recruiting

Barrett's Esophagus Related Neoplasia (BERN) Project

for
Barrett's Esophagus, Neoplasms, Gastroesophageal Reflux
Location: Kansas City MO
Sponsor: Midwest Biomedical Research Foundation

Sex: All

Age: 18+

Code: NCT00590239

Recruiting

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

for
Advanced Malignant Solid Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT04511039

Phase 1, Recruiting

XTX301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Hackensack NJ, Pittsburgh PA, Canton OH,
Sponsor: Xilio Development, Inc.

Sex: All

Age: 18+

Code: NCT05684965

Phase 1, Phase 2, Recruiting

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06409065

Recruiting

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, Ottawa, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06532565

Phase 1, Recruiting

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

for
Cancer, Cancer, Lung
Location: Lebanon NH, Philadelphia PA, Fairfax VA, Toronto,
Sponsor: Conjupro Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05948865

Phase 1, Recruiting

Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Upland CA, Lancaster CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 65+

Code: NCT06022965

Recruiting

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

for
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 0+

Code: NCT06295965

Recruiting

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for
Solid Tumor
Location: Fairfax VA, Myrtle Beach SC, Durham NC, Miami FL,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06874335

Phase 1, Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: LigaChem Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06774963

Phase 1, Recruiting

Community-Based Physical Activity Intervention for Underserved Cancer Survivors

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06206863

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial